 
        
        Prof. Sakai
       
      
        
          General goal and approaches of our lab
        
        
          The general goal of our lab is the 3D organization of cultured
          organ/tissue-derived cells such as liver or pancreas cells in various
          scales for regenerative medicine and cell-based assay for drug or
          chemical screenings without having to resort to animal testing. In our
          body,
          
        
          - Cells are hierarchically organized at a very high cell density
- The vascular system consistently supplies nutrients and removes
            waste/metabolites, thus attaining very high per-volume-based
            functionality.
 
     
    
      However, full arrangement of such vascular systems in vitro is a
      challenging task to achieve due to the complexity of to simultaneously
      optimizing 3D high-density cellular organization and mass transfer
      between the cells and flow channels.
    
    
      The most important step is to overcome the conflicting issues in
      various scales required by relevant applications. I believe academic
      knowledge of chemical engineering will give the basis for the
      optimization. For example, if we intend to organize large tissue
      equivalents for implantation therapy, the tissue should at least be
      arranged with a 3D branching/joining flow channel network as in vivo
      vasculature and the channels should be perfused with suitable culture
      medium containing oxygen carriers. Also, in order to make a small
      tissue for cell-based assays, we have to organize the cells to create
      an environment that the cells reorganize as their original tissues. At
      the same time, we need to pay special attention to mass transfers
      between the cells and the incubation medium, so that various kinetic
      parameters concerning metabolism are the same as those obtained in
      vivo. Chemical engineering undeniably gives a firm basis not only for
      analysis/description of these issues but also for further optimization
      and designing the suitable tissue-based devices/systems in various
      scales.
    
    
      In order to realize cultured cell-based therapy or assays, we need to
      integrate knowledge and technologies from various disciplines in a
      well-balanced manner; that is, basic biology of growth,
      differentiation and maturation of human stem cells or organ
      progenitors, advanced engineering such as micropatterning,
      microfluidics, microfabrication or biomaterials, and medical or
      pharmaceutical knowledge about diseases and responses against therapy
      or administration of drugs. Due to the increasing complexity and
      versatility of current science and engineering, it is difficult to
      integrate the necessary technologies in one laboratory. We are
      therefore actively organizing and participating in collaborations with
      various research groups. To efficiently perform such
      objective-oriented integration, we use the objective-oriented frame of
      mind of chemical engineering. For example, we first set a final goal,
      then layout all the necessary knowledge and technologies with
      appropriate time points, and finally we implement the research and
      development along the roadmap. By doing this, the time for achieving
      the goal is minimized and even if some novel but unanticipated
      innovation emerges in related areas, we can judge the feasibility of
      relevant innovation. Even for regenerative medicine and development of
      cell-based assays, setting our basis on the chemical engineering
      discipline is important. Indeed, cell-culture related chemical
      engineering encompasses the basic biological findings and their
      applications via advanced engineering technologies.
    
   
  
    
      When engineers do research on human body systems, there are three
      typical approaches: from metabolism/biochemistry (the target is
      endoderm-derived organs), mechanics (mesoderm-derived organs) and
      informatics (ectoderm-derived organs). Because our main concerns are
      transport/metabolism-related aspect of the human body, our tentative
      targets are liver, pancreas or kidney for regenerative medicine and
      small intestine, lung, liver or kidney for cell-based assays. The
      typical research approach is as follows; first, design tissues in terms
      of cell-to-cell interaction and mass transfer according to the
      requirements of the relevant application, then culture stem/progenitor
      cells, and finally complete the devices/systems using advanced
      engineering technologies.
    
   
  
    
      We welcome students or researches who have interest in 3D organ
      engineering. Since our lab participates in education and research at
      graduate levels (both master and doctoral courses), we seek motivated
      students not only from Tokyo University but also other universities all
      over the world. We also welcome postdoctoral researchers according to
      the financial situation. If you are interested in our lab, feel free to
      contact me (sakaiyasu[at]chemsys.t.u-tokyo.ac.jp) or Dr. Nishikawa
      (masaki[at]chemsys.t.u-tokyo.ac.jp), the research associate of our lab,
      and visit our lab. We can accept students from two departments in the
      Graduate School of Engineering; the Department of Chemical System
      Engineering and the Department of Bioengineering. Although there are no
      obvious differences in the thesis research, the curriculums are
      completely different, so please choose your department
      carefully.
    
    
      Because we focus on the best integration of knowledge and technologies
      toward the final goal, I ask lab members to adopt an objective-oriented
      way of thinking and to constantly acquire knowledge about biosystems.
      Once you adopt such an attitude, you do not have to be afraid even if
      you happen to hold a completely different position in the future.